This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Parliament is calling for regulators to audit pharmaceuticalcompanies that have made misleading statements to the public about their Covid-19 vaccines. The oversight body noted the communications had not been subject to the regulatory approval process. A member of the U.K.
Pharmacists can typically serve as a communication bridge between the physician and the patient. The constant communication between the provider and the pharmacist strengthens the treatment decisions made for the patient, leading to positive treatment outcomes.
August 1st 2025 Navigating Distrust: Pharma in the Age of Social Media Miranda Schmalfuhs Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceuticalcompanies and the patients they aim to serve.
How will RFK Jr’s American dream for vaccines play out? Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceuticalcompany ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.
Allen, PhD, chief scientific officer, Chimerix, a Jazz PharmaceuticalsCompany, in the press release. "We're proud to deliver precisely the kind of transformative innovation we strive for, and we congratulate our combined Chimerix and Jazz team, and the community who worked together tirelessly to bring this treatment forward.
Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News FDA gives accelerated approval to Jazz Pharma’s diffuse midline glioma therapy Modeyso is expected to be commercially available in late summer 2025. The overall response rate (ORR) was 22%, with a median duration of response of 10.3
How will RFK Jr’s American dream for vaccines play out? Zentiva Group has entered into a licence and supply agreement with pharmaceuticalcompany Lupin for the commercialisation of the latter’s biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets.
It represents one of the highest-risk stages in sterile pharmaceutical manufacturing, where even minute contamination can render entire batches unusable. The optimal time is far earlier than most companies realise, ideally during late preclinical or early Phase I planning, rather than waiting until manufacturing needs become urgent.
How will RFK Jr’s American dream for vaccines play out? This report looks at marketed therapies and their sales projections, pipeline drug trends, and key development challenges for pharmaceuticalcompanies, as well as the role of CDMOs in targeted modality development and what to look for in a development and manufacturing partner.
Find out more This trade deal puts the pharmaceutical industry at risk of losing between $13bn and $19bn, with consequences that extend beyond short-term financials. This could hinder innovation and pipeline investment, reducing the much-needed pace of therapeutic innovation across the industry.
How will RFK Jr’s American dream for vaccines play out? Leading parenteral packaging provider Datwyler, for example, operates its FirstLine® manufacturing facilities across North America, Europe, and Asia, enabling pharmaceuticalcompanies to procure stoppers and plungers that meet the same high standards from around the world.
How will RFK Jr’s American dream for vaccines play out? The initiative comes at a crucial time, as British pharmaceuticalcompanies are significantly increasing their investments in the United States. GSK invested $800m in drug substance and drug product manufacturing facilities in the US in October 2024.
How will RFK Jr’s American dream for vaccines play out? The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceuticalcompanies to invest in the country.
Katarina Zahedi, pharma analyst at GlobalData, comments: “These investments reflect a growing trend among pharmaceuticalcompanies to bolster domestic operations in response to geopolitical pressures and potential tariffs on imported pharmaceuticals.” Give your business an edge with our leading industry insights.
Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Manufacturing issues at Novo facility disrupt Regeneron drug review Issues were picked up during an FDA inspection of Novo Nordisk-owned Catalent’s mammoth filling plant. Give your business an edge with our leading industry insights.
Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News Pharma CEOs downplay impact of tariffs amid rising cost concerns Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern. Give your business an edge with our leading industry insights.
He was also CEO of La Jolla PharmaceuticalCompany from 2011 to 2019, leading the development of a blood pressure drug that failed to meet sales expectations. In particular, Tidmarsh said he wants to boost efficiency in reviews and establish more consistency in communication to sponsors working in the “same disease state.”
It feels like in the US, pharmaceuticalcompanies are capitalising on people’s frustration and desperation to lose weight.” I don’t understand why medication costs are so much higher in the US compared to Europe, though I’ve noticed prices can vary across European countries too,” said Helena. “It
Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. lev radin via Shutterstock. lev radin via Shutterstock. Data Insights The gold standard of business intelligence.
Discover how pharmaceuticalcompanies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Discover how pharmaceuticalcompanies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces.
Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump administration. Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr has embarked on a mission to reset vaccine regulation and evidence generation in the US.
The report also says that the administration is considering splitting CBER into two groups, with one focused solely on vaccines. One would be focused on overall therapeutics, while the other would focus solely on vaccines. President Trump reportedly pushed for the removal of Vinay Prasad from his position at CBER.
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.
As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.
Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Good, empathetic design allows the science to shine.
Humans are diverse and communications to engage us need to be inclusive. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected. Today, people are culturally, socially, and demographically diverse.
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
RSV researchers at major pharmaceuticalcompanies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceuticalcompanies are pushing to develop drugs and vaccines for RSV with these populations in mind.
After a long period of inactivity in RSV vaccine development , two pharmaceuticalcompanies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.
To combat such challenges, pharmaceuticalcompanies need to adopt processes that are not just efficient, but agile. Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceuticalcompanies can ensure drug production runs smoothly – even under stress.
She says she is “truly amazed” about what the industry has achieved in such a short time when it comes to innovations, vaccines and treatments. “When we come together like this, innovation can happen a lot faster.”. Connect with Dr Tunnah at [link] or [link].
People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively. The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. .
Use of these platforms was however already trending up before the crisis, and there’s every sign demand will stay high from now on, according to Sjors van den Camp, commercial director at Online Seminar – a company whose heritage in this sector goes back more than a decade. The crisis that changed everything.
Vaccines have been an essential part of protecting public health for decades. However, despite the overwhelming evidence for their effectiveness and safety, there has been an increasing trend of vaccine hesitancy in recent years. What is vaccine hesitancy? Are there any long-term risks with vaccines?
With the adoption of digital technologies gaining traction in many industries, pharmaceuticalcompanies must take advantage of digitalisation within its research and development (R&D) sector. Using digital means we can streamline communications, facilitate better patient engagement, and ultimately improve retention rates.
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Data will always be central to everything we do, as it has the power to communicate the potential of a new treatment to change a person’s life. About the author.
Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. How to improve payer engagement with tailored value communication.
As we come up on a year and a half of the COVID-19 pandemic, with the global roll out of vaccines slowly gathering pace and big pharma riding high in the opinion charts, the biopharmaceutical sector would do well to learn lessons from the banks.
USAID aimed to help by supporting a project called Map & Match, which looked at which digital systems were in use globally that had relevance to various aspects of the COVID-19 response, such as a vaccination system, a supply chain or logistics management system, et cetera.
Artificial intelligence can assist governments and healthcare institutions in combating pandemics , including monitoring and predicting outbreaks, speeding up diagnostics and research, repurposing existing drugs, and even accelerating vaccine design and development. AI in life sciences is a lot more than just a tool for optimization.
The healthcare industry is evolving rapidly, with data and digital technologies transforming everyday communications as we know them. The customer experience will be driven by innovation in communications . Communication is possible 24/7 in the digital world. The last two years have brought about an online revolution.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content